Chemical Structure (Chlordiazepoxide 01)
Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 71186-006
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 71186-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Vilvet Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Chemical Structure (Chlordiazepoxide 02)
Principal Display Panel (100 Capsule Bottle Label)
This text mentions guidelines for administering and storing a medication containing Chlordiazepoxide HCI and Clidinium Bromide, which come in capsules and should be kept in a light-resistant container. The capsules should be taken orally as prescribed by a physician, and kept out of the reach of children. In case of accidental overdose, a doctor or poison control center should be contacted immediately. The medication should be stored at room temperature, with some leeway for temperature excursions. For more product information or to report a serious adverse event, a phone number and a website are provided. The medication is only available by prescription and is manufactured by Vilvet Pharmaceuticals Inc. in Pennsylvania.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
